Medicamen Biotech Market Cap

Medicamen Biotech has a market cap or net worth of 3.15 billion as of April 29, 2026. Its market cap has decreased by -50.48% in one year.

Market Cap

3.15B

Enterprise Value

3.10B

Revenue

1.72B

Ranking

n/a

PE Ratio

42.44

Stock Price

248.00

Market Cap Chart

Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 3.15B, an increase of 2,806.49%. That is a compound annual growth rate of 17.14%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	3.15B	-31.69%
Dec 31, 2025	4.62B	-28.94%
Dec 31, 2024	6.50B	-14.77%
Dec 29, 2023	7.62B	-27.09%
Dec 30, 2022	10.45B	-3.50%
Dec 31, 2021	10.83B	86.37%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sat Kartar Life	3.19B
Medico Remedies	3.41B
Speciality Medicines	3.04B
Trident Lifeline	3.00B
Kerala Ayurveda	2.99B
Ambalal Sarabhai Enterprises	2.70B
Everest Organics	2.61B
Albert David	4.06B

Market Cap Rankings